A. K. Kakkar
A. K. Kakkar publishes mostly in Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery, on topics such as Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes and Blood Coagulation and Thrombosis Mechanisms.
- World rank
- #1,672,597 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #126,354 of 367,258
- Works
- 104
- Citations
- 5.3k
- Citations per work
- 51.0
What does A. K. Kakkar research?
A. K. Kakkar's work is mostly in Medicine (67%), Economics, Econometrics and Finance (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7067.3%
- Medicine7067.3%
- Everything else2928.2%
- Social Sciences54.5%
- 1Cardiology and Cardiovascular Medicine26% of their works
- 2Internal Medicine20% of their works
- 3Surgery10% of their works
- 4Hematology7% of their works
- 5Economics and Econometrics4% of their works
- 6Epidemiology4% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Blood Coagulation and Thrombosis Mechanisms
- Health Systems, Economic Evaluations, Quality of Life
- Heparin-Induced Thrombocytopenia and Thrombosis
- Central Venous Catheters and Hemodialysis
- Acute Ischemic Stroke Management
- Cardiac, Anesthesia and Surgical Outcomes
Which keywords describe A. K. Kakkar's research?
The keywords of their largest research topics: Antithrombotic Therapy, Diagnosis, Risk Factors, Pulmonary Embolism, Venous Thromboembolism, Guidelines, Anticoagulant Therapy and Atrial Fibrillation.
- Perioperative
- Thrombolysis
- Central Venous Catheterization
- Thrombosis
- Quality of Life
- Thrombin
- Atrial Fibrillation
- Guidelines
- Pulmonary Embolism
- Diagnosis
- Antithrombotic Therapy
- Risk Factors
- Venous Thromboembolism
- Anticoagulant Therapy
- Protease-Activated Receptors
- Cost-effectiveness Analysis
- Heparin-Induced Thrombocytopenia
- Catheter-Related Infections
- Ischemic Stroke
- Cardiac Risk
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Antithrombotic Therapy702 topics
- Diagnosis632 topics
- Risk Factors622 topics
- Pulmonary Embolism551 topic
- Venous Thromboembolism551 topic
- Guidelines472 topics
- Anticoagulant Therapy411 topic
- Atrial Fibrillation411 topic
- Protease-Activated Receptors151 topic
- Thrombin151 topic
- Cost-effectiveness Analysis101 topic
- Quality of Life101 topic
- Heparin-Induced Thrombocytopenia81 topic
- Thrombosis81 topic
- Catheter-Related Infections71 topic
- Central Venous Catheterization71 topic
- Ischemic Stroke71 topic
- Thrombolysis71 topic
- Cardiac Risk61 topic
- Perioperative61 topic
Where does A. K. Kakkar work?
A. K. Kakkar's main affiliation in the publication record is Thrombosis Research Institute, United Kingdom.
How many publications and citations does A. K. Kakkar have?
OpenAlex counts 104 works and 5,306 citations for A. K. Kakkar, an h-index of 26, ranking #1,672,597 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named A. K. Kakkar
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about A. K. Kakkar. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.